To determine the factors that in uence risk of cervical cancer after three consecutive negative Pap smears.
Results:
The sample consisted of 10,509 women, who contributed 28,309 intervals, and 371 cervical cancer cases. The incidence rate of invasive squamous cervical cancer increased with time since last screen up to six years. Women with a history of dysplasia remained at elevated risk for squamous cancer, hazard ratio=2.6 (95% con dence interval [CI]=1.9, 3.4) but age or previous procedure were not related to risk. No relationship between time since last screen and non-squamous cancer risk was found although history of a previous procedure was signi cant. The marginal effectiveness of Pap smears declined with increasing frequency of use.
Conclusions: This study con rmed the preventive effect of Pap smear screening and its dependency on frequency of use. Women with a history of dysplasia, prior to three consecutive negatives, were at increased risk of developing invasive squamous cervical cancer compared with women with no such history. 
P
ap smear screening in asymptomatic women permits the identi cation of pre-malignant lesions of the cervix. The successful treatment of these lesions provides an effective method to decrease the risk of subsequent invasive cervical cancer. Despite the discovery that infection with certain types of human Papilloma virus (HPV) is the trigger for the vast majority of cervical cancer cases, 1,2 and the emerging opportunity for vaccination 3 , screening with a Pap smear, or some variant of it, is likely to remain the principal mechanism for disease control in western countries over the next decade.
Recommendations for the use of the Pap smear have been produced by a number of national and international organizations. These guidelines are broadly similar, 4 typically recommending that, where resources permit, screening should begin soon after the start of sexual activity and continue periodically until late in life. However, frequencies differ with some jurisdictions screening every ve years, 5 whereas in North America the norm is to screen every one to two years.
We wished to examine the effect of screening frequency and history on the risk of invasive cervical cancer in women aged 20-69 years subsequent to three consecutive negative Pap smears. These women are considered to be eligible for less frequent screening than annual screening by some guidelines in Canada, [6] [7] [8] and the United States. 9
METHODS
Data was obtained from two sources: the British Columbia Cancer Registry (Registry), a population based cancer registry and the British Columbia Cervical Screening Program (Cytdb); a program that includes all Pap smears performed under the provincial medical plan. Cytdb also includes data on select gynecologic procedures, including colposcopy, and pathology reports on women with Pap smears. 10 A cohort design was used with members being drawn from the women who had a Pap smear recorded in Cytdb. To be eligible for this study women had to have three consecutive negative screens after 1976 and be within the age range 20-69 during in the period 1 January 1994 and 31 December 1999. To qualify as a screen, the specimen had to be taken from the cervix or endocervix, with no symptoms noted on the test requisition (to exclude tests taken as part of a diagnostic process) and be judged adequate for interpretation. For this study a screen was classi ed as negative if the result provided by the laboratory to the physician did not indicate cancer, squamous dysplasia or glandular atypia. Women satisfying these eligibility criteria were considered to be at risk whilst they had a uterus. A woman was classi ed as having had a hysterectomy, and no longer at risk, if Cytdb contained a record of this procedure being performed, the Pap smear requisition indicated it, or if cytologic specimens were no longer indicated as coming from the cervix or endocervix. The date of hysterectomy was assumed to be the date of the rst of these events. Because of the large size of the cohort a one percent random sample was used to estimate its characteristics.
Cases of invasive cervical cancer diagnosed between 1 January 1994 and 31 December 1999 were identi ed from the Registry. These were linked, using probabilistic record linkage, to the cohort and data on Pap smear usage were appended to each case record. To identify multiple records belonging to the same individual recorded under different Pap history identity numbers (aliasing) the study sample was linked, using probabilistic record linkage, to the cohort. The following variables were used in the linkage: personal health number (an identity number issued by the provincial medical plan), birth name, current name and birth date. Study records were also linked, using name and birth date, to death noti cations for British Columbia supplied by the Vital Statistics Agency, British Columbia Ministry of Health.
The data on subjects in the study sample were converted into intervals: each interval began with a third negative screen (after age 20 years) and ended with the rst of another negative screen, the diagnosis of cervical cancer, death, hysterectomy, reaching age 70 years or the date of 31 December 1999. Records for analysis were created for each interval comprising: total time at risk, age at start of interval, time from beginning of interval until 1 January 1994, history of previous cytologic abnormality and history of previous clinical cervical procedure. Intervals contributed to time at risk only during the calendar period of 1994-99. The resulting set of all study intervals is referred to as the study sample.
For this analysis cancers occurring subsequently to a third consecutive negative with no intervening abnormal Pap smear were classi ed as interval cancers; all others were referred to as screen-detected cancers. This implied that cancers occurring subsequently to an abnormal screen, without three intervening consecutive negative screens, were classi ed as screen-detected irrespective of whether an abnormal screen led to diagnosis. This de nition was adopted since we were interested in the effect of screening policy (i.e. those with three preceding negative screens) and not the effect of subsequent management policy.
The effect of multiple factors on the risk of disease was modelled using Cox regression for left-truncated and rightcensored data. 11 Tests of signi cance and con dence intervals were based on partial likelihood statistics. Rates of disease were calculated using the subject-years method, weighted to account for sampling, with individual risk multiplied by hazard ratios obtained from the Cox regression. Where indicated a kernel function smoother was applied to the event history data weighted to account for the data sampling. 12 Cumulative risks of disease for different screening frequencies, adjusted for mortality and hysterectomy, were calculated using the population hazard rates of disease, 13 and hysterectomy rates obtained from a population sample of the British Columbia population (unpublished data). Con dence intervals for the cumulative risk were based on bootstrap estimates using 1000 replications. 14 
RESULTS
The one percent random sample contained 20,121 women. Of these 1445 were determined to have other aliases in the cohort and the data for these were added. This changed the effective sampling fraction from 1% to 1.08%. No case was found to have an alias. After exclusion of women without a history of three negative screens, or who were not at risk during the study period there remained 10,509 women contributing 28,309 intervals to the analysis. The median interval length was 18 months. Since rates beyond 10 years were likely to be unstable and were not of interest in this analysis we censored such intervals at 10 years. Table 1 provides the distribution of number of women and years at risk by various factors for the study sample.
Of 958 cases of invasive cervical cancer occurring in women aged 20-69 in the period 1994-99, 371 are included in this study. The reasons for exclusion were as follows: previous history of cervical cancer (6) , no history of Pap smears in British Columbia (114), no history of three consecutive negative Pap smears (413) and diagnosed more than 10 years after the last negative screen (54). The distribution of the 371 cases by histology, age, stage, time from last negative and time from last abnormal screen is given in Table 2 . Sixty-six per cent of cases were squamous histology and 26% of these were interval cancers vs 46% of the nonsquamous.
Smoothed estimates of cancer incidence rates, by time since last negative screen, are shown in Figure 1 for squamous and other types. Risk of squamous cancer showed a strong dependency on time since last screen whilst there was not a strong relationship for the other histologic types (non-squamous).
A Cox model was tted to the study sample and invasive squamous cancer cases including age, history of abnormal cytology and previous cervical procedure as categorical variables. The results are given in Table 3 . Only history of previous dysplasia was signi cantly related to risk (p<0.0001). The difference in risk by dysplasia severity was not signi cant with a combined hazard ratio of 2.6 (95% CI=1.9, 3.4). Examination of hazard plots revealed no departure from proportionality by history of dysplasia. In a similar analysis of non-squamous cancer cases, age (p=0.11) and history of glandular atypia (p=0.50) were not related to risk. However, history of a previous cervical procedure was related to risk(p=0.002), with a combined hazard ratio of 3.7 (95% CI=2.4, 5.6).
The probability of developing squamous cancer in women with, or without, a history of dysplasia was calculated using the results from the Cox regression and the sampling fraction. The resulting estimates of cumulative risk over time since last negative smear are displayed in Figure 2 .
The cumulative risk over time since last negative screen ( Figure 2 ) was used to calculate the cumulative risk between 20 and 69 years of developing squamous cervical cancer for women with no history of dysplasia for various screening frequencies. This risk, and the required number of Pap smears, were then adjusted for the competing effects of mortality and hysterectomy assuming independence (Table 4 ). As expected, the likelihood of disease development declined with increasing screen frequency. Differences in the calculated cumulative risks and associated number of screens were then used to calculate the marginal effectiveness of changes in Pap screen frequency expressed as the number of Pap smears required to prevent one squamous cancer ( Table 4 ). The marginal value of extra Pap smears declined with increasing frequency with an estimated 37,900 screens required to prevent a single cancer at annual compared with biennial use (Table 4 ).
DISCUSSION
The ndings of this study are similar to previously published reports showing that women have a reduced risk of invasive squamous cervical cancer following a negative Pap smear. [15] [16] [17] In the study reported here risk is low in the rst year and then increases almost linearly until about six years after which it stabilizes (Figure 1) , indicating that the protective effect of the negative screen is exhausted. Pap smears provided little preventive effect for non-squamous cervical cancer and this did not extend beyond three years (Figure 1 ). This is in agreement with ndings elsewhere. 18 Recommendations for screening in Canada 8, 19 and the US 9 indicate that two or three consecutive negative screens are required before anything other than annual screening should be considered. Less than 50% of cancer cases diagnosed in British Columbia during the study period were in women with three earlier negative screens, an observation similar to that made previously. 20 This indicates that alterations in the screening among these women has limited capacity to reduce the population burden of disease. The relationship found in this study between risk and time since last negative screen was different from an earlier international study 15 where risk was found to increase in a more pronounced sigmoid pattern. The difference between annual screening and screening every ten years or more was similar for the two studies. The linear relationship found in this study implies larger differences in risk between screening frequencies of intervals less than three years. In this study we included individuals within our cohort as long as they had had three negative consecutive screens earlier and had not developed cervical cancer. Studies of screen frequency are in uenced by the effectiveness of management of those who test positive. In British Columbia, over the study period, the practice was conservative and colposcopy was recommended for a nding of severe dysplasia or worse, two consecutive moderate dysplasias or three consecutive mild dysplasias over a two year period. Otherwise repeat cytology at varying intervals was recommended in cases of dysplasia. A more aggressive management practice may have reduced the eventual numbers of cancers. Current recommendations indicate that cases of moderate dysplasia should receive immediate colposcopic assessment.
The existence of a single cervical cancer screening program for over 50 years, with data available for 25 years, allowed us to examine the effect of previous cytologic abnormality on risk subsequent to three negative screens. The results of this analysis suggest that three consecutive negative results do not imply that women have the same risk of invasive squamous cervical cancer regardless of earlier cytology. Although this may be partially due to the existence of false-negative results it seems more likely to be due to these women having a higher intrinsic risk of disease given the disease etiology and the persistence of human Papilloma virus (HPV) infection. 21 This study did not nd a statistically signi cant relationship between age and squamous cancer risk although the hazard ratios were generally smaller for older ages. Since older age is associated with increased risk in the general population this nding may seem unexpected however we believe it is understandable. Older women who persistently screen negative are unlikely to have accumulated the genetic changes that are believed to be the cause of the relationship seen between age and risk seen in most epithelial malignancies. It is also probable that older women are less likely to be newly exposed to HPV, the primary etiologic agent for cervical cancer development. Thus populations such as this are likely to see declining risks with age as has been seen in other studies of early cancer and its precursors. 22, 23 The estimation of the relationship between risk and screening interval length using observational data is methodologically challenging. 24 The de nition of test eligibility, 25 the speci cation of the appropriate interval 26 and case-control selection, 27 are known to in uence estimates of risk. As speci cation of these parameters has varied across studies of Pap smear screening the direct comparison of relative hazards is problematic. Within studies the relative relationship between screening intervals is likely to be more consistent thus allowing some inferences to be drawn.
Using estimates from this study, risk declined as screening frequency increased so that annual or biennial screening reduces the 50 year cumulative risk (in the age range 20-69) of squamous cancer to below one per 1000 in women who are never found to have dysplasia (Table 4 ). We did not include non-squamous cancer in any estimates of the bene ts of screening since it was small in this study. The marginal expenditure of resources, as re ected by the number of Pap smears required, achieves diminishing disease control improvements as the screening intensity increases (Table 4 ). National recommendations for Canada specify three-yearly screening. 8 Using the results of this study (Table  4) , this would suggest a resource-effectiveness threshold of approximately one cancer prevented per 10,000 screens, since otherwise biennial screening would be indicated. Annual screening was found to be resource intense requiring approximately 38,000 extra screens to prevent a single cancer.
We found that women with a history of dysplasia were at increased risk of subsequent invasive cervical cancer even after three intervening consecutive negative screens. The magnitude of increased risk supports more frequent screening of such women. Dividing the nal column of Table 4 by 2.6, the relative risk of squamous cancer in women with a history of dysplasia, provides estimates of the marginal resource-effectiveness of screening in such women. Thus for annual compared with biennial screening would require approximately 15,000 extra screens per cancer prevented. For biennial compared with every three years it would be 4500 screens. If we use the (inferred) threshold of 10,000 screens per cancer prevented this would suggest screening women with a history of dysplasia biennially in jurisdictions where every three year screening is recommended.
In conclusion we were able to demonstrate the effect of screening interval for women with three preceding negative screens and found that any program of regular re-screening would place them at low risk for the development of squamous cervical cancer. Women with a history of cervical dysplasia had a higher risk that justi ed a higher screening frequency.
